Chellamani Harini, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spasms, Infantile | 19 | 2024 | 300 | 7.370 |
Why?
|
Spasm | 10 | 2024 | 131 | 1.520 |
Why?
|
Epilepsy | 12 | 2023 | 3317 | 1.500 |
Why?
|
Vigabatrin | 8 | 2023 | 88 | 1.430 |
Why?
|
Adrenocorticotropic Hormone | 6 | 2023 | 619 | 1.260 |
Why?
|
Anticonvulsants | 13 | 2023 | 1921 | 0.990 |
Why?
|
Seizures | 11 | 2024 | 2996 | 0.970 |
Why?
|
Prednisolone | 3 | 2023 | 326 | 0.760 |
Why?
|
Electroencephalography | 16 | 2024 | 6282 | 0.730 |
Why?
|
Syndrome | 5 | 2024 | 3271 | 0.590 |
Why?
|
Hormones | 1 | 2021 | 865 | 0.550 |
Why?
|
Corpus Callosum | 2 | 2023 | 752 | 0.490 |
Why?
|
Infant | 23 | 2024 | 36485 | 0.470 |
Why?
|
Seizures, Febrile | 1 | 2015 | 109 | 0.460 |
Why?
|
Epilepsies, Partial | 3 | 2023 | 431 | 0.460 |
Why?
|
Glucocorticoids | 1 | 2021 | 2163 | 0.370 |
Why?
|
Down Syndrome | 1 | 2019 | 916 | 0.350 |
Why?
|
Monitoring, Physiologic | 1 | 2018 | 1794 | 0.340 |
Why?
|
Patient Readmission | 1 | 2023 | 3283 | 0.310 |
Why?
|
Retrospective Studies | 18 | 2024 | 81659 | 0.310 |
Why?
|
Preoperative Care | 2 | 2018 | 2252 | 0.300 |
Why?
|
Magnetic Resonance Imaging | 6 | 2021 | 36582 | 0.300 |
Why?
|
Hippocampus | 1 | 2021 | 3777 | 0.300 |
Why?
|
Child | 21 | 2024 | 80771 | 0.230 |
Why?
|
Biogenic Amines | 1 | 2024 | 53 | 0.230 |
Why?
|
Child, Preschool | 13 | 2024 | 42606 | 0.220 |
Why?
|
Preoperative Period | 2 | 2018 | 564 | 0.210 |
Why?
|
Brain | 4 | 2023 | 27163 | 0.210 |
Why?
|
Hemispherectomy | 1 | 2022 | 40 | 0.200 |
Why?
|
Movement Disorders | 2 | 2024 | 462 | 0.200 |
Why?
|
Humans | 41 | 2024 | 767040 | 0.180 |
Why?
|
Mosaicism | 1 | 2023 | 480 | 0.170 |
Why?
|
Feedback | 1 | 2024 | 797 | 0.170 |
Why?
|
Treatment Outcome | 12 | 2023 | 65295 | 0.170 |
Why?
|
Epilepsy, Generalized | 2 | 2019 | 181 | 0.160 |
Why?
|
Male | 24 | 2024 | 364203 | 0.150 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2019 | 88 | 0.150 |
Why?
|
Female | 23 | 2024 | 396660 | 0.140 |
Why?
|
Hospital Units | 1 | 2018 | 141 | 0.140 |
Why?
|
Dopamine | 1 | 2024 | 1581 | 0.140 |
Why?
|
Age of Onset | 1 | 2024 | 3344 | 0.130 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2017 | 171 | 0.130 |
Why?
|
Standard of Care | 1 | 2020 | 569 | 0.130 |
Why?
|
Homeodomain Proteins | 1 | 2024 | 2429 | 0.120 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 357 | 0.120 |
Why?
|
Single-Blind Method | 1 | 2018 | 1587 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 601 | 0.110 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39317 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1600 | 0.110 |
Why?
|
Receptors, GABA-A | 1 | 2017 | 624 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2024 | 2592 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3112 | 0.100 |
Why?
|
Status Epilepticus | 1 | 2018 | 459 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3234 | 0.100 |
Why?
|
Cerebral Infarction | 1 | 2017 | 968 | 0.100 |
Why?
|
Head | 1 | 2017 | 926 | 0.090 |
Why?
|
Prospective Studies | 6 | 2023 | 54886 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2021 | 10748 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2006 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8736 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2013 | 913 | 0.080 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1424 | 0.080 |
Why?
|
Boston | 2 | 2021 | 9360 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 41718 | 0.080 |
Why?
|
Triazoles | 1 | 2014 | 903 | 0.080 |
Why?
|
Genetic Testing | 1 | 2022 | 3591 | 0.080 |
Why?
|
Electrodes, Implanted | 1 | 2013 | 835 | 0.080 |
Why?
|
Adolescent | 9 | 2018 | 89046 | 0.080 |
Why?
|
Epilepsia Partialis Continua | 1 | 2008 | 25 | 0.070 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2011 | 390 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5537 | 0.070 |
Why?
|
Benzodiazepines | 1 | 2014 | 1137 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2017 | 1481 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 996 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12158 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6489 | 0.060 |
Why?
|
Patient Compliance | 1 | 2014 | 2697 | 0.060 |
Why?
|
Temporal Lobe | 1 | 2011 | 1717 | 0.060 |
Why?
|
Genetic Variation | 1 | 2019 | 6611 | 0.060 |
Why?
|
Infant, Premature | 1 | 2013 | 2125 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2016 | 12986 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2013 | 2075 | 0.050 |
Why?
|
Cosyntropin | 1 | 2022 | 34 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2023 | 26396 | 0.050 |
Why?
|
Mouth Mucosa | 1 | 2023 | 435 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2024 | 661 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20169 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2850 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2022 | 551 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 74886 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14672 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15925 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15424 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15851 | 0.040 |
Why?
|
Ceftriaxone | 1 | 2019 | 175 | 0.040 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2008 | 1498 | 0.040 |
Why?
|
Hospitalization | 1 | 2018 | 10815 | 0.040 |
Why?
|
Videoconferencing | 1 | 2020 | 209 | 0.040 |
Why?
|
Protein Structure, Secondary | 1 | 2019 | 1211 | 0.030 |
Why?
|
Speech Disorders | 1 | 2017 | 178 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9108 | 0.030 |
Why?
|
Muscle Hypotonia | 1 | 2017 | 166 | 0.030 |
Why?
|
United States | 1 | 2023 | 72971 | 0.030 |
Why?
|
Zambia | 1 | 2016 | 273 | 0.030 |
Why?
|
Prognosis | 1 | 2015 | 29963 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1883 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 24299 | 0.030 |
Why?
|
Health Resources | 1 | 2020 | 948 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2018 | 1836 | 0.030 |
Why?
|
Neurology | 1 | 2020 | 785 | 0.020 |
Why?
|
Tuberous Sclerosis | 1 | 2020 | 1039 | 0.020 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 810 | 0.020 |
Why?
|
Tanzania | 1 | 2016 | 1406 | 0.020 |
Why?
|
Sclerosis | 1 | 2011 | 211 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 1023 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20741 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4280 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2531 | 0.020 |
Why?
|
Pedigree | 1 | 2017 | 4539 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13411 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7059 | 0.010 |
Why?
|
Evoked Potentials, Motor | 1 | 2008 | 463 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6310 | 0.010 |
Why?
|
Encephalitis | 1 | 2008 | 441 | 0.010 |
Why?
|
Caregivers | 1 | 2016 | 2302 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7435 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2008 | 1736 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26325 | 0.010 |
Why?
|
Telemedicine | 1 | 2020 | 3110 | 0.010 |
Why?
|
Pilot Projects | 1 | 2016 | 8732 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5363 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40154 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16718 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30211 | 0.010 |
Why?
|
Young Adult | 1 | 2014 | 59980 | 0.000 |
Why?
|
Adult | 1 | 2014 | 223317 | 0.000 |
Why?
|